InsidersTradesSigma

Campbell David Alan

CEO

Cumul. flow

Total declarations

Company

—

▲ Purchases (0 ops.)

€5m

▼ Sales (6 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

6

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the detailed record of transactions filed by Campbell David Alan. Insider active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 7 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €5m. History available since 27 September 2024. The latest transaction was disclosed on 7 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations7 total

▼

Campbell David Alan

President and CEOExecutives7 Jan 2025Janux Therapeutics, Inc.

$300,00423SEC ↗

5,000 shares@ US$60.00085.8% of flowCommon StockSEC:0001415889-25-001165:0

◆

Campbell David Alan

President and CEOExecutives2 Jan 2025Janux Therapeutics, Inc.

22SEC ↗

81,000 shares0Common StockSEC:0001415889-25-000675:0

▼